5.33
price down icon3.09%   -0.17
after-market アフターアワーズ: 5.23 -0.10 -1.88%
loading
前日終値:
$5.50
開ける:
$5.49
24時間の取引高:
69,382
Relative Volume:
0.46
時価総額:
$54.12M
収益:
$52.29M
当期純損益:
$-73.52M
株価収益率:
-8.0758
EPS:
-0.66
ネットキャッシュフロー:
$-100.45M
1週間 パフォーマンス:
+6.18%
1か月 パフォーマンス:
+4.72%
6か月 パフォーマンス:
-36.32%
1年 パフォーマンス:
-45.16%
1日の値動き範囲:
Value
$5.16
$5.6761
1週間の範囲:
Value
$4.95
$5.75
52週間の値動き範囲:
Value
$3.61
$13.44

Precision Biosciences Inc Stock (DTIL) Company Profile

Name
名前
Precision Biosciences Inc
Name
セクター
Healthcare (1154)
Name
電話
919-314-5512
Name
住所
302 EAST PETTIGREW STREET, DURHAM, NC
Name
職員
108
Name
次回の収益日
2024-11-04
Name
最新のSEC提出書
Name
DTIL's Discussions on Twitter

DTIL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
DTIL
Precision Biosciences Inc
5.33 54.12M 52.29M -73.52M -100.45M -0.66
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
493.84 122.76B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
602.64 61.38B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
614.76 36.37B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.56 30.12B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
244.90 24.70B 3.81B -644.79M -669.77M -6.24

Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-10 アップグレード BMO Capital Markets Market Perform → Outperform
2024-04-30 開始されました Guggenheim Buy
2022-06-17 開始されました BMO Capital Markets Outperform
2022-06-09 ダウングレード William Blair Outperform → Mkt Perform
2020-07-27 再開されました BTIG Research Buy
2020-04-03 ダウングレード Goldman Buy → Neutral
2020-03-05 開始されました Stifel Buy
2020-02-25 開始されました William Blair Outperform
2019-08-09 開始されました BTIG Research Buy
2019-07-16 開始されました H.C. Wainwright Buy
2019-04-22 開始されました Barclays Overweight
2019-04-22 開始されました Goldman Buy
2019-04-22 開始されました JP Morgan Overweight
2019-04-22 開始されました Jefferies Buy
すべてを表示

Precision Biosciences Inc (DTIL) 最新ニュース

pulisher
Apr 23, 2025

Trading (DTIL) With Integrated Risk Controls - news.stocktradersdaily.com

Apr 23, 2025
pulisher
Apr 16, 2025

DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up - TradingView

Apr 16, 2025
pulisher
Apr 16, 2025

Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B | DTIL Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 15, 2025

FDA fast tracks Precision BioSciences’ hepatitis B treatment By Investing.com - Investing.com South Africa

Apr 15, 2025
pulisher
Apr 15, 2025

Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In-Class Gene Editing Therapy Designed to Eliminate the Root Cause of Chronic Hepatitis B - BioSpace

Apr 15, 2025
pulisher
Apr 15, 2025

Precision BioSciences stock rises following FDA Fast Track designation By Investing.com - Investing.com India

Apr 15, 2025
pulisher
Apr 15, 2025

Precision BioSciences Gets FDA Fast Track Label for PBGENE-HBV - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Apr 15, 2025
pulisher
Apr 15, 2025

FDA Fast Tracks Precision BioSciences' (DTIL) Hepatitis B Gene E - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

FDA fast tracks Precision BioSciences’ hepatitis B treatment - Investing.com Australia

Apr 15, 2025
pulisher
Apr 15, 2025

Precision BioSciences stock rises following FDA Fast Track designation - Investing.com Australia

Apr 15, 2025
pulisher
Apr 15, 2025

FDA Fast Tracks Precision BioSciences' (DTIL) Hepatitis B Gene Editing Program | DTIL Stock News - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Precision Biosciences Receives U.S. FDA Fast Track Designation For Pbgene-Hbv - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

Revolutionary Gene Editing Treatment for Hepatitis B Wins FDA Fast Track Status - Stock Titan

Apr 15, 2025
pulisher
Apr 04, 2025

SEC Form PRE 14A filed by Precision BioSciences Inc. - Quantisnow

Apr 04, 2025
pulisher
Apr 01, 2025

Precision BioSciences to Participate in the 24th Annual Needham Virtual Healthcare Conference - 01net

Apr 01, 2025
pulisher
Apr 01, 2025

Gene Editing Pioneer Precision BioSciences Reveals Latest ARCUS Platform Progress at Major Healthcare Conference - Stock Titan

Apr 01, 2025
pulisher
Mar 28, 2025

Precision Biosciences director Kevin Buehler buys $21,122 in stock - Investing.com Australia

Mar 28, 2025
pulisher
Mar 28, 2025

Precision Biosciences director Melinda Brown buys $8,735 in stock By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Precision Biosciences director Melinda Brown buys $8,735 in stock - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Precision Biosciences director Kevin Buehler buys $21,122 in stock By Investing.com - Investing.com UK

Mar 28, 2025
pulisher
Mar 27, 2025

Precision BioSciences (DTIL) Reports Q4 Loss, Misses Revenue Estimates - MSN

Mar 27, 2025
pulisher
Mar 27, 2025

Precision Biosciences director Germano Geno J purchases $17,225 in stock By Investing.com - Investing.com Australia

Mar 27, 2025
pulisher
Mar 27, 2025

Precision Biosciences director Germano Geno J purchases $17,225 in stock - Investing.com India

Mar 27, 2025
pulisher
Mar 27, 2025

Precision BioSciences: Q4 Earnings Snapshot - Big Rapids Pioneer

Mar 27, 2025
pulisher
Mar 26, 2025

Precision BioSciences Reports Positive 2024 Financial Results - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Precision BioSciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides Business Update - CRISPR Medicine News

Mar 26, 2025
pulisher
Mar 26, 2025

Precision BioSciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 26, 2025

PRECISION BIOSCIENCES Earnings Results: $DTIL Reports Quarterly Earnings - Nasdaq

Mar 26, 2025
pulisher
Mar 26, 2025

Precision Biosciences Reports Fourth Quarter And FY 2024 Results - MarketScreener

Mar 26, 2025
pulisher
Mar 26, 2025

Precision BioSciences Inc Q4 Sales Decline - Nasdaq

Mar 26, 2025
pulisher
Mar 25, 2025

Precision Biosciences CEO sells $5,359 in stock By Investing.com - Investing.com Australia

Mar 25, 2025
pulisher
Mar 25, 2025

Precision Biosciences CEO sells $5,359 in stock - Investing.com India

Mar 25, 2025
pulisher
Mar 25, 2025

Character Biosciences Raises $93 Million Series B to Advance Precision Medicine for Progressive Eye Diseases - Business Wire

Mar 25, 2025
pulisher
Mar 23, 2025

PRECISION BIOSCIENCES Earnings Preview: Recent $DTIL Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 23, 2025
pulisher
Mar 23, 2025

Gene Editing Tools Market Growth Demand, Segment Analysis - openPR.com

Mar 23, 2025
pulisher
Mar 21, 2025

Precision BioSciences to Report Fourth Quarter and Fiscal Year 2024 Results on March 26, 2025 - BioSpace

Mar 21, 2025

Precision Biosciences Inc (DTIL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
大文字化:     |  ボリューム (24 時間):